Dropdown items
My Academies

Personal Library

Account settings

Scientific Standards for Studies on Modified Risk Tobacco Products (2012)

Chapter: Appendix D: Meeting Agendas

Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.

Previous chapter
Page of 350
Search this publication

Previous Chapter: Appendix C: Committee Biographies

Page 347 Cite

Suggested Citation: "Appendix D: Meeting Agendas." Institute of Medicine. 2012. Scientific Standards for Studies on Modified Risk Tobacco Products. Washington, DC: The National Academies Press. doi: 10.17226/13294.

Appendix D

Meeting Agendas

Thursday, February 3, 2011

Keck Center of the National Academies
500 Fifth Street, NW
Washington, DC 20001

1:00-1:15 pm	Committee Introductions and Chair’s Opening Jane Henney Committee Chair

1:10-1:30 pm	Charge to the Committee Lawrence Deyton, M.D., M.S.P.H. Director Center for Tobacco Products U.S. Food and Drug Administration (FDA)

1:30-2:00 pm	Discussion About the Charge Committee and FDA Representatives

2:00-3:00 pm	Public Comment

3:00 pm	Adjourn

Page 348 Cite

Monday, May 9, 2011

Embassy Suites 900
Tenth Street, NW
Washington, DC 20001

9:45-10:00 am	Welcome and Introductions Jane Henney Committee Chair
10:00-11:30 am	Panel Discussion I: Tobacco Manufacturers Moderator: Peter Honig

	10:00-11:00 am: Presentations by industry representatives 11:00-11:30 am: Questions from the Committee

	• Introduction Standards for pre-clinical studies Mike Ogden Senior Director of Regulatory Oversight R.J. Reynolds Tobacco Company

	• Standards for studies on in vitro models of disease Chris Proctor Chief Scientific Officer British American Tobacco

	• Standards for clinical studies and biomarkers Mohamadi Sarkar Senior Principal Research Scientist Altria Client Services

	• Population communication and risk perception Lars Erik Rutqvist Senior Vice President for Scientific Affairs Swedish Match

	• Summary J. Daniel Heck Principal Scientist Lorillard Tobacco Company

Page 349 Cite

11:30 am- 12:00 pm	Andrew Salmon Senior Toxicologist and Chief Air Toxicology and Risk Assessment Section Office of Environmental Health Hazard Assessment California Environmental Protection Agency

12:00-1:00 pm	Lunch

1:00-1:30 pm	David Jacobson-Kram Associate Director of Pharmacology and Toxicology Office of New Drugs Food and Drug Administration

1:30-2:00 pm	Peter G. Shields Professor of Medicine and Oncology Deputy Director, Lombardi Comprehensive Cancer Center Georgetown University Mirjana Djordjevic Health Scientist Administrator Tobacco Control Research Branch National Cancer Institute

2:00-2:30 pm	John Baron Professor of Medicine Dartmouth Medical School

2:30-2:45 pm	Break

2:45-3:15 pm	Brenda Edwards Associate Director Surveillance Research Program National Cancer Institute

3:15-3:45 pm	Ruth S. Day Director Medical Cognition Laboratory Duke University

3:45-4:15 pm	David Mendez Associate Professor Department of Health Management and Policy University of Michigan School of Public Health

Page 350 Cite

4:15-4:30 pm	Break
4:30-6:00 pm	Panel Discussion II: public health representatives Moderator: Dan Carpenter

	4:30-5:30 pm: Presentations by public health representatives
	5:30-6:00 pm: Questions from the Committee

	• David Abrams Executive Director The Schroeder Institute for Tobacco Research and Policy Studies Professor, Department of Health, Behavior and Society The Johns Hopkins Bloomberg School of Public Health

	• Tom Glynn Director, Cancer Science and Trends Director, International Cancer Control American Cancer Society

	• Mark Greenwold Director, Regulatory Affairs Campaign for Tobacco-Free Kids

	• Rose Marie Robertson Chief Science Officer American Heart Association

	• Mitch Zeller Vice President for Policy and Strategic Communications Pinney Associates

6:00 pm	Adjourn